Delivery Order SPE2DB20D3101-SPE2DB24FQUP3
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,076.56 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,299,676 units of 40mg Atorvastatin tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,885,038 units of 20 mg Atorvastatin tablets, a cardiovascular medication, with a ceiling value of $2,259.75. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award is for the delivery of 4,561,450,705 tablets of 80 mg Atorvastatin, a generic cardiovascular medication, to the Defense Logistics Agency (DLA). The $2,184.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 10, 2023, with a completion date of July 11, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,094.07 firm fixed-price delivery order is for the supply of 4,561,290 units of Atorvastatin 10 mg tablets, a cardiovascular medication, with a completion date of June 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,011.22, is for the delivery of 4560784583 units of Atorvastatin 40 mg tablets to support military healthcare programs. The award is a Delivery Order contract with a firm-fixed price pricing type, with a completion date of May 2, 2023. This contract is not designated as a set-aside and was...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 tablets of Atorvastatin 20 mg, a generic medication used to treat high cholesterol. The contract has a firm fixed price of $1,150.05 and a completion date of May 16, 2025. The contract is not set aside and was competed openly. Amerisourcebergen Drug Corp holds a larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,491.03 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Atorvastatin 40 mg, a commonly prescribed statin medication used to manage cholesterol and cardiovascular health. The contract is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and was awarded on September 17, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a $8,604.56 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,565,780 units of 80 mg Atorvastatin tablets, a cardiovascular medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,607.82, is for the delivery of 1,000 units of Atorvastatin 40 mg tablets, a medication used to treat cardiovascular conditions. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This order was not set aside for any specific business category. Amerisourcebergen...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,449.51 firm-fixed-price delivery order is for the supply of 4,559,305,598 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQUP3Delivery Order
This federal contract award is for the delivery of 1,000 tablets of 40 mg Atorvastatin, a prescription medication used to treat high cholesterol and related cardiovascular conditions. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract has a ceiling value of $1,897.08 and a completion date of November 15, 2023. It is a firm-fixed-price delivery order contract, meaning the price is set and not subject to adjustment. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order contract is likely part of the larger IDC vehicle, enabling the efficient procurement of essential medications for DoD facilities and personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/14/23 |